Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 224 (4647), 395-6

Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by Proglumide

Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by Proglumide

L R Watkins et al. Science.

Abstract

Exogenous cholecystokinin selectively antagonizes opiate analgesia, which suggests that endogenous cholecystokinin may act physiologically as an opiate antagonist and may play a role in opiate tolerance. The use of the selective cholecystokinin antagonist proglumide provided a test of these hypotheses in rats that were either inexperienced with or tolerant to opiates. Proglumide potentiated analgesia produced by morphine and endogenous opiates and seemed to reverse tolerance. These results suggest that endogenous cholecystokinin systems oppose the action of opiates.

Similar articles

See all similar articles

Cited by 29 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback